FREELINE THERAPEUTICS HLDGS's ticker is FRLN and the CUSIP is 35655L107. A total of 20 filers reported holding FREELINE THERAPEUTICS HLDGS in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $2,163,215 | -25.9% | 4,702,641 | -20.6% | 0.04% | -31.0% |
Q4 2022 | $2,917,370 | -28.7% | 5,920,765 | -0.5% | 0.06% | -27.5% |
Q3 2022 | $4,091,000 | -20.8% | 5,950,000 | 0.0% | 0.08% | -27.9% |
Q2 2022 | $5,168,000 | +30.2% | 5,950,000 | +65.0% | 0.11% | +79.0% |
Q1 2022 | $3,970,000 | -41.2% | 3,606,192 | +3.5% | 0.06% | -27.9% |
Q4 2021 | $6,746,000 | -42.7% | 3,485,656 | 0.0% | 0.09% | -44.5% |
Q3 2021 | $11,779,000 | -40.4% | 3,485,656 | +40.2% | 0.16% | -41.5% |
Q2 2021 | $19,757,000 | -33.7% | 2,485,656 | 0.0% | 0.26% | -40.0% |
Q1 2021 | $29,818,000 | -32.6% | 2,485,656 | 0.0% | 0.44% | -34.9% |
Q4 2020 | $44,266,000 | +24.3% | 2,485,656 | +6.1% | 0.68% | -2.6% |
Q3 2020 | $35,620,000 | – | 2,343,304 | – | 0.70% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CHI Advisors LLC | 1,379,843 | $11,246,000 | 2.62% |
Novo Holdings A/S | 2,361,229 | $19,244,000 | 0.85% |
Ally Bridge Group (NY) LLC | 401,747 | $3,274,000 | 0.81% |
SECTORAL ASSET MANAGEMENT INC | 640,714 | $5,222,000 | 0.42% |
FRAZIER MANAGEMENT LLC | 550,000 | $4,483,000 | 0.41% |
TFG Asset Management GP Ltd | 750,000 | $6,113,000 | 0.33% |
Eventide Asset Management | 2,485,656 | $19,757,000 | 0.26% |
AXA S.A. | 1,111,510 | $9,058,000 | 0.01% |
Woodline Partners LP | 25,932 | $211,000 | 0.00% |
WELLINGTON MANAGEMENT GROUP LLP | 2,001,951 | $16,315,000 | 0.00% |